全基因測序市場－全球產業規模、佔有率、趨勢、機會及預測（依產品/服務、類型、工作流程、應用、最終用戶、地區和競爭格局分類），2021-2031年

全球全基因測序市場預計將從 2025 年的 21.8 億美元成長到 2031 年的 45.1 億美元，複合年成長率為 12.88%。

全基因測序(WGS) 是一種綜合性的實驗室技術，它能夠在一次實驗中解碼生物體的全部 DNA 序列，包括編碼區和非編碼區。該領域的發展主要得益於定序成本的大幅下降以及對精準醫療日益成長的需求，以改善腫瘤和罕見遺傳疾病的診斷。例如，英國生物銀行於 2025 年成功完成了對約 490,640 名參與者全基因組序列的全面分析，展現了大規模人群基因組分析所需的擴充性。

然而，市場發展面臨的主要障礙在於處理和儲存高Petabyte系統產生的大量數據所面臨的挑戰。分析、保存和解讀PB級基因組數據需要先進的計算基礎設施，這造成了經濟和技術上的障礙，限制了其在資源有限的臨床環境中的廣泛應用。

市場促進因素

定序成本和耗材的大幅下降是市場擴張的關鍵驅動力，使得高通量定序平台能夠惠及專業研究機構以外的機構。定序技術的進步推動了價格的快速下降，使實驗室能夠從標靶基因檢測過渡到全基因組分析工作流程，從而降低營運成本並獲得更優的診斷結果。根據2025年2月題為「Ultima Genomics生產力提升超過50%」的新聞稿，UG 100 Solaris系統的商業化發布將定序成本降低至每百萬reads 0.24美元，從而有效地實現了每read 80美元的基因組分析成本。價格的下降降低了臨床應用的經濟門檻，使醫療系統能夠在不犧牲準確性或覆蓋深度的前提下，將全面的基因組分析納入癌症和遺傳疾病的標準診斷流程。

同時，政府主導的人口定序計劃的興起，對大規模定序能力的需求也顯著成長。各國正大力投資國家生物銀行項目，以收集多樣化的遺傳訊息，加速藥物研發，並推動精準醫療在不同族群的應用。 2025年2月，美國國立衛生研究院（NIH）在一份題為“‘我們所有人’計劃參與者數據擴充50%以上”的新聞稿中宣布，其研究資料集已擴展至包含超過63.3萬名個體的詳細資訊，凸顯了聯邦政府授權下數據生成的規模之大。這一趨勢在全球普遍存在，各國都在努力招募不同人群參與縱貫研究。例如，「我們的未來健康」計畫在2025年達到了250萬志願者的里程碑，進一步顯示了國家基因組資源在生物醫學研究領域的快速擴張。

市場挑戰

管理和儲存海量基因組數據的巨大挑戰目前是全球全基因測序市場的主要阻礙因素。雖然產生原始資料的成本有所下降，但處理、儲存和保護這些資料所需的下游生物資訊學基礎設施的相關費用卻不斷增加。因此，出現了一個嚴重的瓶頸：DNA定序的技術能力已經超過了有效維護所產生資料集的能力，這使得小規模的醫療機構難以利用這些技術。

根據全球基因組健康聯盟 (GA4GH) 發布的《2025 年展望》報告，其相關基礎設施技術支援處理超過 10 Petabyte的基因組數據。如此大規模的資訊處理需要企業級儲存系統和高效能運算環境，而這些成本對於資源有限的臨床機構而言往往難以承受。因此，資料管理所需的大量資本和營運成本直接阻礙了全基因組定序在標準臨床環境中的廣泛應用，並將市場擴張主要限制在資金雄厚的研究中心。

市場趨勢

將人工智慧 (AI) 整合到基因組數據分析中，正從根本上改變生物資訊流程，以 GPU 加速架構取代傳統的基於 CPU 的工作流程。這項轉變解決了二次分析中的一個關鍵瓶頸：變異檢測和比對的速度歷來慢於原始資料產生速度。深度學習演算法的應用使實驗室能夠以驚人的速度分析序列讀段，從而實現近乎即時的診斷結論，這對於緊急臨床診療至關重要。例如，NVIDIA 在 2024 年 11 月發表的論文《利用加速泛基因組比對發現新的生物學見解》中指出，其 Parabricks v4.4 軟體在單一 GPU 系統上實現了端到端 30 倍全基因組定序分析，耗時縮短不到 30 分鐘，顯著縮短了從樣本採集到獲得結果的時間。

同時，市場正大幅增加混合定序和長讀長定定序技術的應用，以解決標準短讀長定序平台難以分析的複雜基因組區域。研究人員正利用長讀長定序技術，透過詳細揭示結構變異、大片段插入和重複序列，有效地填補參考基因組序列的空白，從而提高罕見疾病的診斷準確性。高通量長讀長定序系統的快速普及，突破了傳統方法的限制，提供了全基因組的可視性，也印證了這項技術進步。根據Pacific Biosciences於2025年1月發布的最新2024年度報告，該公司定序儀的數據輸出量在2024年成長了81%，顯示先進基因組研究對高品質定序數據的需求日益成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球全基因測序市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品/服務（設備、耗材、服務）分類
  • 按類型（大規模全基因測序、小規模全基因測序）
  • 依工作流程（序列預處理、定序、資料分析）
  • 依應用領域（人類全基因測序、植物全基因測序、動物全基因測序、微生物全基因測序）
  • 按最終用戶（學術/研究機構、醫院/診所、製藥/生技公司、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美全基因測序市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲全基因測序市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區全基因測序市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲全基因測序市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲全基因測序市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

13. 全球全基因測序市場：SWOT 分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI Group
• QIAGEN NV
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Whole Genome Sequencing Market is projected to expand from USD 2.18 Billion in 2025 to USD 4.51 Billion by 2031, registering a CAGR of 12.88%. Whole Genome Sequencing (WGS) serves as an exhaustive laboratory technique that deciphers an organism's entire DNA sequence, encompassing both coding and non-coding areas within a single process. Growth in this sector is largely underpinned by the dramatic decrease in sequencing expenses and the escalating need for precision medicine to enhance oncology and rare genetic disorder diagnostics. For example, the UK Biobank successfully coordinated the thorough analysis of whole genome sequences for roughly 490,640 participants in 2025, highlighting the scalability necessary for extensive population genomics.

Nevertheless, a major obstacle hindering market progression is the difficulty associated with handling and archiving the colossal amounts of data produced by high-throughput systems. The necessity for sophisticated computational infrastructure to analyze, secure, and interpret petabytes of genomic data imposes a financial and technical hurdle that limits widespread implementation in clinical environments with constrained resources.

Market Driver

The significant reduction in sequencing costs and consumables acts as a major driver for market expansion, making high-throughput platforms accessible to facilities other than exclusive research institutes. Advancements in sequencing architecture are rapidly lowering prices, permitting laboratories to transition from targeted panels to whole genome workflows, thereby attaining superior diagnostic results at reduced operational costs. According to a February 2025 press release titled 'Ultima Genomics Increases Output by Over 50%', the commercial introduction of the UG 100 Solaris system reduced sequencing costs to $0.24 per million reads, effectively facilitating an $80 genome. This trend of falling prices lowers the financial threshold for clinical implementation, enabling healthcare systems to incorporate thorough genomic profiling into standard diagnostics for oncology and genetic diseases without sacrificing accuracy or coverage depth.

Simultaneously, the increase in government-sponsored population genomics projects is creating significant demand for extensive sequencing capabilities. Countries are making substantial investments in national biobanking initiatives to gather diverse genetic information, which hastens drug development and the application of precision medicine across various demographic groups. In February 2025, the National Institutes of Health announced in 'All of Us Adds Data from 50% More Participants' that the program had broadened its research dataset to encompass details from over 633,000 participants, highlighting the immense scale of data generation mandated by federal directives. This pattern is observed worldwide as initiatives strive to enlist diverse groups for longitudinal research; for example, Our Future Health achieved a milestone of 2.5 million volunteers in 2025, further demonstrating the swift growth of national genomic resources for biomedical study.

Market Challenge

The formidable task of administering and archiving vast quantities of genomic data currently serves as a major constraint on the Global Whole Genome Sequencing Market. Although the expense of producing raw sequence data has decreased, the costs linked to the downstream bioinformatic infrastructure required to process, store, and protect this data have increased. This results in a substantial bottleneck where the technical ability to sequence DNA exceeds the capacity to efficiently maintain the generated datasets, thereby stopping smaller healthcare institutions from utilizing these technologies.

As reported by the Global Alliance for Genomics and Health in 2025, the organization's associated infrastructure technologies supported the processing of over 10 petabytes of genomic data. Handling information of this magnitude demands enterprise-grade storage systems and high-performance computing environments, which are frequently too costly for clinical settings with limited resources. Consequently, the significant capital and operational expenses necessary for data stewardship directly impede the wider adoption of whole genome sequencing in standard medical practice, restricting market expansion primarily to well-financed research hubs.

Market Trends

The incorporation of Artificial Intelligence for Genomic Data Analysis is fundamentally transforming bioinformatic processes by substituting traditional CPU-based workflows with accelerated GPU-focused architectures. This transition tackles the crucial bottleneck of secondary analysis, where the pace of variant calling and alignment has traditionally been slower than raw data generation. By employing deep learning algorithms, laboratories can now analyze sequence reads with exceptional speed, allowing for near real-time diagnostic conclusions that are vital for urgent clinical care. For instance, NVIDIA announced in November 2024 via their 'Discover New Biological Insights with Accelerated Pangenome Alignment' release that their Parabricks v4.4 software accomplished end-to-end 30x whole genome sequencing analysis in under 30 minutes on a single-GPU system, drastically reducing the time from sample collection to results.

Concurrently, the market is observing a significant shift toward the Adoption of Hybrid and Long-Read Sequencing Technologies to address complex genomic areas that standard short-read platforms cannot access. Researchers are increasingly leveraging long-read abilities to thoroughly define structural variants, large insertions, and repetitive elements, effectively bridging gaps in reference assemblies and enhancing diagnostic outcomes for rare diseases. This technical progression is demonstrated by the swift adoption of high-throughput long-read systems that offer full genomic visibility surpassing legacy method limitations; according to Pacific Biosciences' January 2025 '2024 Annual Report' update, data output from the company's sequencers increased by 81% in 2024, indicating growing demand for high-fidelity reads in advanced genomic research.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI Group
• QIAGEN N.V.
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc.

Report Scope

In this report, the Global Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Whole Genome Sequencing Market, By Product & Service

• Instruments
• Consumables
• Services

Whole Genome Sequencing Market, By Type

• Large Whole Genome Sequencing
• Small Whole Genome Sequencing

Whole Genome Sequencing Market, By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

Whole Genome Sequencing Market, By Application

• Human Whole Genome Sequencing
• Plant Whole Genome Sequencing
• Animal Whole Genome Sequencing
• Microbial Whole Genome Sequencing

Whole Genome Sequencing Market, By End User

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Genome Sequencing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.

Available Customizations:

Global Whole Genome Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Whole Genome Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Instruments, Consumables, Services)
  • 5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
  • 5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
  • 5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
  • 5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Whole Genome Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Type
  • 6.2.3. By Workflow
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Whole Genome Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Whole Genome Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Whole Genome Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Whole Genome Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Type
  • 7.2.3. By Workflow
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Whole Genome Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Whole Genome Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Whole Genome Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Whole Genome Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Whole Genome Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Whole Genome Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Type
  • 8.2.3. By Workflow
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Whole Genome Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Whole Genome Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Whole Genome Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Whole Genome Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Whole Genome Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Whole Genome Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Type
  • 9.2.3. By Workflow
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Whole Genome Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Whole Genome Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Whole Genome Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Whole Genome Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Type
  • 10.2.3. By Workflow
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Whole Genome Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Whole Genome Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Whole Genome Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Whole Genome Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Oxford Nanopore Technologies plc.
• 15.4. Pacific Biosciences of California, Inc.
• 15.5. BGI Group
• 15.6. QIAGEN N.V.
• 15.7. Agilent Technologies, Inc.
• 15.8. ProPhase Labs, Inc.
• 15.9. Psomagen, Inc
• 15.10. Azenta US Inc.

16. Strategic Recommendations

17. About Us & Disclaimer